Search research articles
Contact Us
Filters
Showing results (41-50 of 133) with videos related to
Page
of 14
Sort By:
British Journal of Cancer
|
December 21, 2021
No evidence of disease versus residual disease in long-term responders to first-line HER2-targeted therapy for metastatic breast cancer
Zachary Veitch, Domen Ribnikar, Derek Tilley, et al.
Frontiers in Oncology
|
February 28, 2022
Therapeutic Targeting of Minimal Residual Disease to Prevent Late Recurrence in Hormone-Receptor Positive Breast Cancer: Challenges and New Approaches
David W Cescon, Kevin Kalinsky, Heather A Parsons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2009
Presentation of nonfinal results of randomized controlled trials at major oncology meetings
Christopher M Booth, Aurélie Le Maître, Keyue Ding, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
September 14, 2024
Microfluidic Platform for Generating and Releasing Patient-Derived Cancer Organoids with Diverse Shapes: Insight into Shape-Dependent Tumor Growth
Sina Kheiri, Ilya Yakavets, Jennifer Cruickshank, et al.
Cancers
|
January 26, 2024
The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers
Suzanne Kazandjian, Emmanuelle Rousselle, Matthew Dankner, et al.
Critical Reviews in Oncology/Hematology
|
December 10, 2021
Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications
Vasudeva Bhat, Sierra Pellizzari, Alison L Allan, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
August 16, 2024
Ionizable Drugs Enable Intracellular Delivery of Co-Formulated siRNA
Kai V Slaughter, Eric N Donders, Michael S Jones, et al.
Journal of Nanobiotechnology
|
May 18, 2026
Multitargeted nanoparticles inhibit cancer invasion by disrupting cancer-associated fibroblast-tumor cell crosstalk and modulating collagen pattern and EMT
Liting Wang, Pei Zhi, Ibrahim Alradwan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 6, 2011
Pharmacogenetic and germline prognostic markers of lung cancer
Anne M Horgan, Boming Yang, Abul Kalam Azad, et al.
Cancer Research
|
May 31, 2019
Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts
Arvind S Mer, Wail Ba-Alawi, Petr Smirnov, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 133) with videos related to
Sort By:
Page
of 14
British Journal of Cancer
|
December 21, 2021
No evidence of disease versus residual disease in long-term responders to first-line HER2-targeted therapy for metastatic breast cancer
Zachary Veitch, Domen Ribnikar, Derek Tilley, et al.
Frontiers in Oncology
|
February 28, 2022
Therapeutic Targeting of Minimal Residual Disease to Prevent Late Recurrence in Hormone-Receptor Positive Breast Cancer: Challenges and New Approaches
David W Cescon, Kevin Kalinsky, Heather A Parsons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2009
Presentation of nonfinal results of randomized controlled trials at major oncology meetings
Christopher M Booth, Aurélie Le Maître, Keyue Ding, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
September 14, 2024
Microfluidic Platform for Generating and Releasing Patient-Derived Cancer Organoids with Diverse Shapes: Insight into Shape-Dependent Tumor Growth
Sina Kheiri, Ilya Yakavets, Jennifer Cruickshank, et al.
Cancers
|
January 26, 2024
The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers
Suzanne Kazandjian, Emmanuelle Rousselle, Matthew Dankner, et al.
Critical Reviews in Oncology/Hematology
|
December 10, 2021
Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications
Vasudeva Bhat, Sierra Pellizzari, Alison L Allan, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
August 16, 2024
Ionizable Drugs Enable Intracellular Delivery of Co-Formulated siRNA
Kai V Slaughter, Eric N Donders, Michael S Jones, et al.
Journal of Nanobiotechnology
|
May 18, 2026
Multitargeted nanoparticles inhibit cancer invasion by disrupting cancer-associated fibroblast-tumor cell crosstalk and modulating collagen pattern and EMT
Liting Wang, Pei Zhi, Ibrahim Alradwan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 6, 2011
Pharmacogenetic and germline prognostic markers of lung cancer
Anne M Horgan, Boming Yang, Abul Kalam Azad, et al.
Cancer Research
|
May 31, 2019
Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts
Arvind S Mer, Wail Ba-Alawi, Petr Smirnov, et al.
Page
of 14